Primaquine Phosphate NDC 0024-1596

NDC codes

FDA NDC Directory

Product NDC (as listed)0024-1596Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00024-1596Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0024-1596-01	00024159601	100 TABLET, FILM COATED in 1 BOTTLE (0024-1596-01)Marketed from Apr 15, 2011

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Primaquine Phosphate
Generic name (nonproprietary): primaquine phosphate
Active ingredients: Primaquine phosphate — 15 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Sanofi-Aventis U.S. LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 008316
Marketing start: Apr 15, 2011
Listing expires: Dec 31, 2027
Identifiers: Product ID 0024-1596_7e15f87d-f34f-4ec2-9da8-a041db792623SPL ID 7e15f87d-f34f-4ec2-9da8-a041db792623SPL set ID 1bfbf4ae-81b8-4160-a00d-6322aadd4b59RxCUI 904170UNII H0982HF78B
Pharmacologic class: Antimalarial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400024159601 followed by a unit qualifier and the quantity

Package 00024-1596-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 11, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Primaquine phosphate Tablets are indicated for the radical cure (prevention of relapse) of vivax malaria.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)